Evaxion - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeEvaxion
Evaxion logo

Evaxion

0 followers

EVAX

Performance

About Evaxion

Evaxion is a pioneering TechBio company that uses artificial intelligence and machine learning technologies to model the immune system and develop novel vaccines for cancer and infectious diseases. Their AI-Immunology platform is clinically validated and can identify therapeutically relevant vaccine targets. The company operates in the field of biotechnology and has a strong presence in Denmark.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Birgitte Rønø

Chief Scientific Officer

Andreas Mattsson

Founder & Chief AI Officer

Helen Tayton-Martin

Chief Executive Officer

Thomas Schmidt

Chief Financial Officer

Key Facts

HQ Location

Hørsholm, Denmark

Founded

2008

Employees

51 - 200

Status

Public

Website

https://evaxion.ai